C. Paustian

发表

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

F. Marincola, D. Sargent, P. Delrio, 2018, The Lancet.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

AN IMMUNOTHERAPY TRIO IN ADVANCED FOR COORDINATED

F. Lund-Johansen, B. Fox, B. Piening, 2020 .

pan-differentiation of CD34pos cells into tumor-competent dendritic cells STAT3- and STAT5-dependent pathways competitively regulate the

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2013 .

cells cells into tumor-competent dendritic pos pan-differentiation of CD34 STAT3- and STAT5-dependent pathways competitively regulate the

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2011 .

J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.

K. Rosenthal, F. B. Moore, P. Cohen, 2010, Vaccine.

STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2008, Blood.

Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells.

B. Czerniecki, Shuwen Xu, P. Cohen, 2011, Human immunology.

Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens.

K. Rosenthal, C. Paustian, D. Zimmerman, 2010, Cellular immunology.

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

F. Marincola, P. Delrio, J. Lee, 2022, Cancers.

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

B. Fox, W. Urba, E. Walker, 2017, Journal of Immunotherapy for Cancer.

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

C. Dubay, B. Fox, W. Urba, 2018, Oncoimmunology.

Targeting regulatory T cells and other strategies to enable cancer vaccines

R. Puri, B. Fox, W. Urba, 2011 .

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

F. Marincola, P. Delrio, J. Lee, 2023, Cancers.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

F. Marincola, P. Delrio, G. Botti, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells

B. Fox, W. Ye, W. Urba, 2014, Journal of Translational Medicine.

Adoptive TIL in HPV-negative oral scca

B. Fox, R. Bell, W. Urba, 2015, Journal of Immunotherapy for Cancer.

Extracellular ATP and Toll-Like Receptor 2 Agonists Trigger in Human Monocytes an Activation Program That Favors T Helper 17

B. Czerniecki, K. Rosenthal, P. Cohen, 2013, PloS one.

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment

B. Fox, C. Bifulco, B. Curti, 2015, Journal of Immunotherapy for Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC

C. Dubay, B. Fox, B. Spieler, 2014, Journal of Immunotherapy for Cancer.

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC

C. Dubay, B. Fox, B. Spieler, 2015, Journal of Immunotherapy for Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.